• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿奇霉素的眼部水平。

Ocular levels of azithromycin.

作者信息

Tabbara K F, al-Kharashi S A, al-Mansouri S M, al-Omar O M, Cooper H, el-Asrar A M, Foulds G

机构信息

Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Arch Ophthalmol. 1998 Dec;116(12):1625-8. doi: 10.1001/archopht.116.12.1625.

DOI:10.1001/archopht.116.12.1625
PMID:9869792
Abstract

OBJECTIVE

To assess azithromycin levels in human serum, aqueous humor, tear fluid, and conjunctival tissue specimens after administration of a single 1-g oral dose of azithromycin.

METHODS

Sixty patients undergoing cataract surgery were included in this analysis. Serum, aqueous, and tear specimens were collected 3, 6, and 12 hours and 1, 2, 3, and 4 days after azithromycin administration. Conjunctival tissue biopsy specimens were collected 1, 2, 3, 4, 6, 8, 10, 12, and 14 days after azithromycin administration. All specimens were subjected to analysis by high-performance liquid chromatography-mass spectrometry.

RESULTS

Azithromycin concentration ranges during the specified sampling times were as follows: serum, 21 to 974 ng/mL; tear, 82 to 2892 ng/mL; aqueous, 10 to 69 ng/mL; and conjunctival, 0.7 to 32 micrograms/g. Levels above the 90% minimal inhibitory concentration (MIC90) for Chlamydia trachomatis were detected after 4 days in all tear samples and after 14 days in all conjunctival tissue specimens following oral azithromycin administration.

CONCLUSION

We demonstrated prolonged high levels of azithromycin in drug-targeted ocular tissue. Prolonged high concentrations of azithromycin in conjunctival tissue make this drug suitable for treatment of conjunctivitis caused by chlamydiae and other susceptible organisms.

摘要

目的

评估单次口服1克阿奇霉素后人体血清、房水、泪液和结膜组织标本中的阿奇霉素水平。

方法

本分析纳入了60例接受白内障手术的患者。在给予阿奇霉素后3、6和12小时以及1、2、3和4天收集血清、房水和泪液标本。在给予阿奇霉素后1、2、3、4、6、8、10、12和14天收集结膜组织活检标本。所有标本均采用高效液相色谱-质谱分析法进行分析。

结果

在指定采样时间内阿奇霉素的浓度范围如下:血清,21至974纳克/毫升;泪液,82至2892纳克/毫升;房水,10至69纳克/毫升;结膜,0.7至32微克/克。口服阿奇霉素后,所有泪液样本在4天后以及所有结膜组织标本在14天后均检测到高于沙眼衣原体90%最小抑菌浓度(MIC90)的水平。

结论

我们证明了阿奇霉素在药物靶向眼组织中的高水平持续存在。结膜组织中阿奇霉素的高浓度持续存在使得该药物适用于治疗由衣原体和其他易感微生物引起的结膜炎。

相似文献

1
Ocular levels of azithromycin.阿奇霉素的眼部水平。
Arch Ophthalmol. 1998 Dec;116(12):1625-8. doi: 10.1001/archopht.116.12.1625.
2
Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.在批准的给药方案期间和之后,阿奇霉素和莫西沙星在人眼结合膜和房水中的药代动力学。
Am J Ophthalmol. 2010 Nov;150(5):744-751.e2. doi: 10.1016/j.ajo.2010.05.039. Epub 2010 Sep 1.
3
Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.在有色家兔中单次及多次给予阿奇霉素后的眼部药代动力学研究。
Curr Eye Res. 2008 Feb;33(2):149-58. doi: 10.1080/02713680701860499.
4
Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.新型眼科 1%阿奇霉素制剂的眼部表面分布和药代动力学。
J Ocul Pharmacol Ther. 2009 Oct;25(5):433-9. doi: 10.1089/jop.2009.0026.
5
Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels.阿奇霉素在沙眼患者中的药代动力学:血清和泪液水平
Ophthalmology. 1998 Apr;105(4):658-61. doi: 10.1016/S0161-6420(98)94020-9.
6
Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.1%阿奇霉素和0.5%莫西沙星滴眼液的结膜组织药代动力学特性:一项在健康成年志愿者中进行的单剂量、随机、开放标签、活性对照试验。
Clin Ther. 2008 Nov;30(11):2005-14. doi: 10.1016/j.clinthera.2008.10.020.
7
Pharmacokinetics of azithromycinin rabbit lacrimal glands and conjunctiv a.
Ophthalmic Res. 1999;31(1):47-52. doi: 10.1159/000055512.
8
Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.贝西沙星对兔、猴和人进行局部给药后的眼药代动力学。
J Ocul Pharmacol Ther. 2009 Aug;25(4):335-44. doi: 10.1089/jop.2008.0116.
9
Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers.在健康志愿者中局部给予单剂量0.5%、1.0%和1.5%的阿奇霉素滴眼液(T1225)后泪液中阿奇霉素的浓度。
Eur J Ophthalmol. 2008 Jan-Feb;18(1):13-20. doi: 10.1177/112067210801800103.
10
Ocular pharmacokinetics of AzaSite Xtra-2% azithromycin formulated in a DuraSite delivery system.采用DuraSite给药系统配制的AzaSite Xtra-2%阿奇霉素的眼药代动力学。
Curr Eye Res. 2009 Jun;34(6):485-91. doi: 10.1080/02713680902919532.

引用本文的文献

1
Pulsed Oral Azithromycin vs 6-Week Oral Doxycycline for Moderate to Severe Meibomian Gland Dysfunction: A Randomized Clinical Trial.脉冲口服阿奇霉素与 6 周口服多西环素治疗中重度睑板腺功能障碍的随机临床试验。
JAMA Ophthalmol. 2023 May 1;141(5):423-429. doi: 10.1001/jamaophthalmol.2023.0302.
2
Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.季节性疟疾化学预防联合阿奇霉素对恶性疟原虫传播的影响:配子体感染性和蚊子适应力。
Malar J. 2021 Jul 27;20(1):326. doi: 10.1186/s12936-021-03855-3.
3
Intense pulsed light for the treatment of Meibomian gland dysfunction: A systematic review and meta-analysis.
强脉冲光治疗睑板腺功能障碍:一项系统评价和荟萃分析。
Exp Ther Med. 2020 Aug;20(2):1815-1821. doi: 10.3892/etm.2020.8838. Epub 2020 Jun 4.
4
Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix.肠道和宫颈沙眼衣原体感染对阿奇霉素治疗的不同敏感性。
Antimicrob Agents Chemother. 2013 Dec;57(12):6290-4. doi: 10.1128/AAC.01405-13. Epub 2013 Oct 7.
5
A European perspective on topical ophthalmic antibiotics: current and evolving options.欧洲视角下的局部眼科抗生素:当前及不断发展的选择
Ophthalmol Eye Dis. 2011 Oct 24;3:29-43. doi: 10.4137/OED.S4866. Print 2011.
6
Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections.1%阿奇霉素滴眼液(AzaSite(®))治疗眼部感染的综述
Ophthalmol Eye Dis. 2012 Feb 23;4:1-14. doi: 10.4137/OED.S7791. Print 2012.
7
Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite) solution in the treatment of ocular infections.1%阿奇霉素眼膏(AzaSite)溶液局部应用于眼部感染治疗的最新进展及批判性评价
Clin Ophthalmol. 2011;5:801-9. doi: 10.2147/OPTH.S13785. Epub 2011 Jun 15.
8
Azithromycin for control of trachoma.阿奇霉素用于沙眼控制。
Community Eye Health. 1999;12(32):55-6.
9
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.1.5%阿奇霉素滴眼液3天疗法与0.3%妥布霉素7天疗法治疗脓性细菌性结膜炎:成人及儿童多中心随机对照试验
Br J Ophthalmol. 2007 Apr;91(4):465-9. doi: 10.1136/bjo.2006.103556. Epub 2006 Oct 18.
10
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.阿奇霉素质量分布对眼部沙眼衣原体抗生素敏感性的影响。
Antimicrob Agents Chemother. 2005 Nov;49(11):4804-6. doi: 10.1128/AAC.49.11.4804-4806.2005.